Product Information

CEPHALEXIN 250 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0650 per ML under NDC 68180044101. Its NADAC has been published 475 times since Oct 18, 2017.

FDA first approved this application on Aug 17, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEPHALEXIN 250 MG/5 ML SUSP

Cephalexin
$0.0650per ML

Strength

250 mg/5mL

NDC

68180044101

Classification

Generic

Dosage Form

FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CEPHALEXIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065234

FDA Approved

8/17/2005

TE Code

AB

On Market Since

9/6/2017

Pharmacological Classes

Price Statistics

The NADAC for CEPHALEXIN 250 MG/5 ML SUSP has been published 475 times since Oct 18, 2017, and over the history we have for it it has declined 53.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0650 per ML
All-time high$0.1399 (Nov 15, 2017)
All-time low$0.0541 (Jul 17, 2024)
52-week high$0.0790
52-week low$0.0650
Median price$0.1007
Average price$0.0984
Largest weekly change+66.4% (Aug 21, 2024)
Weeks tracked475
Tracking sinceOct 18, 2017

Price History

1W

-4.8%

1M

-8.4%

3M

-13.4%

6M

-16.7%

1Y

-14.4%

3Y

-17.4%

5Y

-39.0%

All

-53.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CEPHALEXIN 250 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 250 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.0650 per ML (NDC 68180044101), effective Nov 18, 2026.

How has the price of CEPHALEXIN 250 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEPHALEXIN 250 MG/5 ML SUSP has declined 53.5%. It has been tracked across 475 weekly CMS publications since Oct 18, 2017.

What are the highest and lowest recorded NADAC prices for CEPHALEXIN 250 MG/5 ML SUSP?

Since Oct 18, 2017, the NADAC for CEPHALEXIN 250 MG/5 ML SUSP has ranged from a low of $0.0541 (Jul 17, 2024) to a high of $0.1399 (Nov 15, 2017), with a median of $0.1007 per ML.

Are there cheaper alternatives to CEPHALEXIN 250 MG/5 ML SUSP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEPHALEXIN 250 MG/5 ML SUSP, is $0.0494 per ML — about 24% below CEPHALEXIN 250 MG/5 ML SUSP.

Who manufactures CEPHALEXIN 250 MG/5 ML SUSP?

CEPHALEXIN 250 MG/5 ML SUSP (NDC 68180044101) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.